Experts are concerned that despite the availability of a respiratory syncytial virus (RSV) vaccine for older Canadians, many may be deterred from receiving it due to the out-of-pocket cost. This could potentially result in preventable hospitalizations and even deaths during the cold and flu season. Katherine Ward has more on this issue.
- Pfizer’s RSV vaccine for older adults, pregnant people approved by Health Canada
- RSV vaccine for older Canadians comes at a cost. Why experts are worried